Cotara: Completed Phase I enrollment

Peregrine completed enrollment of 12 patients in the open-label, U.S. Phase I trial evaluating 1.5, 2.0 and 2.5 mCi/cc Cotara administered interstitially via convection-enhanced delivery. ...